CDH1 and bacterial infectious disease: Our findings on the reduced expression of E-cadherin mRNA in RV16-exposed differentiated epithelium upon FP treatment suggest that the treatment with FP, but not BUD, may aggravate RV-induced barrier disruption in vivo, and thus increase the risk of a secondary bacterial infection.